Teva, Active Biotech in advanced trial of MS drug
Reuters - USA
ST: Quote, Profile, Research said on Thursday they would start a clinical Phase III trial of relapsing multiple sclerosis drug Laquinimod. ...
See all stories on this topic

Analyst Available to Comment on Impact to the Pharmaceutical ...
PharmaLive.com (press release) - Newtown,PA,USA
For possible biogeneric forms of Rituxan and Campath, the majority of oncologists said they would prescribe biogeneric versions within one year. ...
See all stories on this topic

Genzyme Stock Rises on Lehman Upgrade
Forbes - NY,USA
Other positive pipeline opportunities include the leukemia drug Campath as a treatment for multiple sclerosis. Questions or comments about this story should ...
See all stories on this topic